167 related articles for article (PubMed ID: 22367688)
1. Distribution, elimination, and biopersistence to 90 days of a systemically introduced 30 nm ceria-engineered nanomaterial in rats.
Yokel RA; Au TC; MacPhail R; Hardas SS; Butterfield DA; Sultana R; Goodman M; Tseng MT; Dan M; Haghnazar H; Unrine JM; Graham UM; Wu P; Grulke EA
Toxicol Sci; 2012 May; 127(1):256-68. PubMed ID: 22367688
[TBL] [Abstract][Full Text] [Related]
2. Brain distribution and toxicological evaluation of a systemically delivered engineered nanoscale ceria.
Hardas SS; Butterfield DA; Sultana R; Tseng MT; Dan M; Florence RL; Unrine JM; Graham UM; Wu P; Grulke EA; Yokel RA
Toxicol Sci; 2010 Aug; 116(2):562-76. PubMed ID: 20457660
[TBL] [Abstract][Full Text] [Related]
3. Alteration of hepatic structure and oxidative stress induced by intravenous nanoceria.
Tseng MT; Lu X; Duan X; Hardas SS; Sultana R; Wu P; Unrine JM; Graham U; Butterfield DA; Grulke EA; Yokel RA
Toxicol Appl Pharmacol; 2012 Apr; 260(2):173-82. PubMed ID: 22373796
[TBL] [Abstract][Full Text] [Related]
4. Ceria-engineered nanomaterial distribution in, and clearance from, blood: size matters.
Dan M; Wu P; Grulke EA; Graham UM; Unrine JM; Yokel RA
Nanomedicine (Lond); 2012 Jan; 7(1):95-110. PubMed ID: 22191779
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution and biopersistence of ceria engineered nanomaterials: size dependence.
Yokel RA; Tseng MT; Dan M; Unrine JM; Graham UM; Wu P; Grulke EA
Nanomedicine; 2013 Apr; 9(3):398-407. PubMed ID: 22960425
[TBL] [Abstract][Full Text] [Related]
6. Toxicity and tissue distribution of cerium oxide nanoparticles in rats by two different routes: single intravenous injection and single oral administration.
Park K; Park J; Lee H; Choi J; Yu WJ; Lee J
Arch Pharm Res; 2018 Nov; 41(11):1108-1116. PubMed ID: 30178439
[TBL] [Abstract][Full Text] [Related]
7. Rat brain pro-oxidant effects of peripherally administered 5 nm ceria 30 days after exposure.
Hardas SS; Sultana R; Warrier G; Dan M; Florence RL; Wu P; Grulke EA; Tseng MT; Unrine JM; Graham UM; Yokel RA; Butterfield DA
Neurotoxicology; 2012 Oct; 33(5):1147-55. PubMed ID: 22750192
[TBL] [Abstract][Full Text] [Related]
8. Lung deposition and extrapulmonary translocation of nano-ceria after intratracheal instillation.
He X; Zhang H; Ma Y; Bai W; Zhang Z; Lu K; Ding Y; Zhao Y; Chai Z
Nanotechnology; 2010 Jul; 21(28):285103. PubMed ID: 20562477
[TBL] [Abstract][Full Text] [Related]
9. Toxicology and carcinogenesis studies of 3,3',4,4'-tetrachloroazobenzene (TCAB) (CAS No. 14047-09-7) in Harlan Sprague-Dawley rats and B6C3F1 mice (gavage studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2010 Nov; (558):1-206. PubMed ID: 21383777
[TBL] [Abstract][Full Text] [Related]
10. Rat hippocampal responses up to 90 days after a single nanoceria dose extends a hierarchical oxidative stress model for nanoparticle toxicity.
Hardas SS; Sultana R; Warrier G; Dan M; Wu P; Grulke EA; Tseng MT; Unrine JM; Graham UM; Yokel RA; Butterfield DA
Nanotoxicology; 2014 Aug; 8 Suppl 1():155-66. PubMed ID: 24350865
[TBL] [Abstract][Full Text] [Related]
11. NTP Toxicology and Carcinogenesis Studies of Salicylazosulfapyridine (CAS No. 599-79-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1997 May; 457():1-327. PubMed ID: 12587019
[TBL] [Abstract][Full Text] [Related]
12. Nanoceria distribution and effects are mouse-strain dependent.
Yokel RA; Tseng MT; Butterfield DA; Hancock ML; Grulke EA; Unrine JM; Stromberg AJ; Dozier AK; Graham UM
Nanotoxicology; 2020 Aug; 14(6):827-846. PubMed ID: 32552239
[TBL] [Abstract][Full Text] [Related]
13. Analytical High-resolution Electron Microscopy Reveals Organ-specific Nanoceria Bioprocessing.
Graham UM; Yokel RA; Dozier AK; Drummy L; Mahalingam K; Tseng MT; Birch E; Fernback J
Toxicol Pathol; 2018 Jan; 46(1):47-61. PubMed ID: 29145781
[TBL] [Abstract][Full Text] [Related]
14. Persistent hepatic structural alterations following nanoceria vascular infusion in the rat.
Tseng MT; Fu Q; Lor K; Fernandez-Botran GR; Deng ZB; Graham U; Butterfield DA; Grulke EA; Yokel RA
Toxicol Pathol; 2014 Aug; 42(6):984-96. PubMed ID: 24178579
[TBL] [Abstract][Full Text] [Related]
15. Bio-distribution and in vivo antioxidant effects of cerium oxide nanoparticles in mice.
Hirst SM; Karakoti A; Singh S; Self W; Tyler R; Seal S; Reilly CM
Environ Toxicol; 2013 Feb; 28(2):107-18. PubMed ID: 21618676
[TBL] [Abstract][Full Text] [Related]
16. Custom cerium oxide nanoparticles protect against a free radical mediated autoimmune degenerative disease in the brain.
Heckman KL; DeCoteau W; Estevez A; Reed KJ; Costanzo W; Sanford D; Leiter JC; Clauss J; Knapp K; Gomez C; Mullen P; Rathbun E; Prime K; Marini J; Patchefsky J; Patchefsky AS; Hailstone RK; Erlichman JS
ACS Nano; 2013 Dec; 7(12):10582-96. PubMed ID: 24266731
[TBL] [Abstract][Full Text] [Related]
17. NTP Toxicology and Carcinogenesis Studies of para-Chloroaniline Hydrochloride (CAS No. 20265-96-7) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1989 Jul; 351():1-256. PubMed ID: 12704433
[TBL] [Abstract][Full Text] [Related]
18. Physiologically based pharmacokinetic modeling of nanoceria systemic distribution in rats suggests dose- and route-dependent biokinetics.
Carlander U; Moto TP; Desalegn AA; Yokel RA; Johanson G
Int J Nanomedicine; 2018; 13():2631-2646. PubMed ID: 29750034
[TBL] [Abstract][Full Text] [Related]
19. Distribution and bioavailability of ceria nanoparticles in an aquatic ecosystem model.
Zhang P; He X; Ma Y; Lu K; Zhao Y; Zhang Z
Chemosphere; 2012 Oct; 89(5):530-5. PubMed ID: 22694776
[TBL] [Abstract][Full Text] [Related]
20. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1996 Aug; 383():1-370. PubMed ID: 12692653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
